Updated on 26 August 2026
Empowering neurodegenerative disease trials
Chief Executive Officer at Poseidon CRO ( Poseidon Research Balkans d.o.o. )
Novi Sad, Serbia
About
For neurodegenerative disease trials, Illyrico can provide the real-world and regional clinical-research infrastructure needed to complement highly specialised scientific programmes.
We can bring:
Feasibility assessment and identification of relevant patient populations.
Clinical-research coordination and investigator engagement.
Patient journey and disease-management mapping.
Real-world evidence to complement clinical-trial endpoints.
Data-driven approaches to identify and characterise potential trial populations.
Access to regional healthcare and research networks through Poseidon.
Experience working across healthcare systems where patient identification and recruitment can be operationally challenging.
Potential consortium role: Clinical-trial partner, recruitment/feasibility partner, RWE partner and regional research-network partner.
Topic
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Medical-grade remote monitoring and digital endpoints for NCD and neurodegenerative clinical trials
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Kai Gand
Grants Manager at Corsano Health
The Hague, Netherlands
Project cooperation
Clinical Research Partner in Neurology and Neurodegenerative Diseases
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Karine Minasyan
Deputy Director for Scientific Development at NeuroKlinik – German Center for Neurology
Yerevan, Armenia
Project cooperation
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Ilias Nikolinakos
EU Grants and Funding Coordinator at Elpen Pharmaceutical Co. Inc.
Athens, Greece